Status:

COMPLETED

The Effects of Cranial Electrotherapy Stimulation (CES) on Brain Function, Brain Chemistry and Mood

Lead Sponsor:

Mclean Hospital

Collaborating Sponsors:

Mending Minds Foundation

Conditions:

Mood

Eligibility:

All Genders

21-55 years

Phase:

NA

Brief Summary

Document whether the Fischer Wallace Cranial Stimulator produces any measurable changes in brain activity.

Detailed Description

The advent of an appreciation that alternative and complementary practices can have some beneficial effect on health has prompted the question of whether there are empirical measures of improvement th...

Eligibility Criteria

Inclusion

  • 21 to 55 years old
  • Otherwise physically healthy (normal physical exam, ECG, blood and urine chemistries)
  • Female participants must use medically approved method of contraception. If barrier method is used, they must agree to using two methods simultaneously (e.g., diaphragm and condom).
  • If on antidepressant or antianxiety medication, must be on a stable prescription regimen with no intentions to change drugs or dose during the next 11 weeks.

Exclusion

  • Opiate maintenance (e.g., methadone or buprenorphine)
  • Drug use (other than nicotine, alcohol, or marihuana) greater than 50 lifetime uses.
  • Meets criteria for current drug abuse or dependence (other than nicotine, alcohol, or marihuana). Past abuse/dependence (greater than 3 years) is acceptable.
  • Meets criteria for alcohol dependence. Past abuse/dependence (greater than 3 years) is acceptable. They may meet criteria for alcohol abuse.
  • Physical health problems
  • History of significant cardiac problems
  • History of seizures
  • Pregnancy
  • Persons with a demand-type cardiac pacemaker
  • Persons receiving vagus nerve simulation
  • Persons receiving deep brain stimulation
  • Participants cannot have any conditions that are contraindicated for MRI

Key Trial Info

Start Date :

May 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT01860677

Start Date

May 1 2010

End Date

June 1 2014

Last Update

June 14 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

McLean Hospital

Belmont, Massachusetts, United States, 02478